XML 33 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
EARNINGS PER COMMON SHARE
6 Months Ended
Jun. 30, 2018
Earnings Per Share [Abstract]  
EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE

The following table sets forth the computation of basic and diluted earnings per share:
 
 
Three months ended
 
Six months ended
 
 
June 30,
 
June 30,
(Dollars in thousands, except per share data)
 
2018
 
2017
 
2018
 
2017
Numerator
 
 
 
 
 
 
 
 
Net income available to common shareholders
 
$
36,418

 
$
22,736

 
$
66,924

 
$
47,150

 
 
 
 
 
 
 
 
 
Denominator
 
 
 
 
 
 
 
 
Basic earnings per common share - weighted average shares
 
97,347,533

 
61,543,478

 
79,599,709

 
61,471,347

Effect of dilutive securities
 
 
 
 
 
 
 
 
Employee stock awards
 
545,374

 
625,031

 
504,914

 
649,706

Warrants
 
539,165

 
65,513

 
524,872

 
66,420

Diluted earnings per common share - adjusted weighted average shares
 
98,432,072

 
62,234,022

 
80,629,495

 
62,187,473

 
 
 
 
 
 
 
 
 
Earnings per share available to common shareholders
 
 

 
 

 
 
 
 
Basic
 
$
0.37

 
$
0.37

 
$
0.84

 
$
0.77

Diluted
 
$
0.37

 
$
0.37

 
$
0.83

 
$
0.76



First Financial has two categories of warrants outstanding to purchase the Company's common stock as of June 30, 2018. The first type of warrant represents the right to purchase one share of common stock, no par value per share, and has an exercise price of $12.11 per share. First Financial had warrants outstanding to purchase 22,698 and 112,233 shares of First Financial's common stock as of June 30, 2018 and 2017, respectively and these warrants expire in December of 2018. The second category of warrant was acquired in the MSFG merger and the Company had one such warrant outstanding as of June 30, 2018.
This warrant represents the right to purchase 793,520 shares of First Financial's common stock at an exercise price of $10.72 per share and expires in January 2019.

Stock options and warrants with exercise prices greater than the average market price of the common shares were not included in the computation of net income per diluted share, as they would have been antidilutive.  Using the end of period price of the Company's common shares, there were no antidilutive options at June 30, 2018 and June 30, 2017.